Eur J Cancer. 2016 May 17;61:137-145. doi: 10.1016/j.ejca.2016.03.009. [Epub ahead of print]
Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
Copyright © 2016 Elsevier Ltd. All rights reserved.
BRCA mutation; Epithelial ovarian cancer; Genetic testing; Probability; Referral
- [PubMed - as supplied by publisher]